Quadrant Capital Group’s NEVRO CORP. NVRO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-59
| Closed | -$345 | – | 2740 |
|
|
2025
Q1 | $345 | Hold |
59
| – | – | ﹤0.01% | 2693 |
|
|
2024
Q4 | $220 | Sell |
59
-104
| -64% | -$480 | ﹤0.01% | 2700 |
|
|
2024
Q3 | $912 | Sell |
163
-652
| -80% | -$4.56K | ﹤0.01% | 2604 |
|
|
2024
Q2 | $6.86K | Buy |
815
+483
| +145% | +$5.15K | ﹤0.01% | 2221 |
|
|
2024
Q1 | $4.79K | Buy |
332
+157
| +90% | +$2.6K | ﹤0.01% | 2328 |
|
|
2023
Q4 | $3.77K | Sell |
175
-482
| -73% | -$8.6K | ﹤0.01% | 2345 |
|
|
2023
Q3 | $12.6K | Buy |
657
+620
| +1,676% | +$13.2K | ﹤0.01% | 1900 |
|
|
2023
Q2 | $941 | Sell |
37
-358
| -91% | -$10.3K | ﹤0.01% | 2505 |
|
|
2023
Q1 | $14.3K | Buy |
395
+205
| +108% | +$7.2K | ﹤0.01% | 1855 |
|
|
2022
Q4 | $7.52K | Sell |
190
-276
| -59% | -$11.5K | ﹤0.01% | 2081 |
|
|
2022
Q3 | $22K | Buy |
466
+135
| +41% | +$6.26K | ﹤0.01% | 1497 |
|
|
2022
Q2 | $15K | Buy |
331
+134
| +68% | +$7.37K | ﹤0.01% | 1459 |
|
|
2022
Q1 | $14K | Sell |
197
-171
| -46% | -$12.3K | ﹤0.01% | 1518 |
|
|
2021
Q4 | $30K | Buy |
368
+163
| +80% | +$16.3K | ﹤0.01% | 1116 |
|
|
2021
Q3 | $24K | Buy |
205
+35
| +21% | +$4.58K | ﹤0.01% | 1176 |
|
|
2021
Q2 | $28K | Sell |
170
-29
| -15% | -$4.53K | ﹤0.01% | 1065 |
|
|
2021
Q1 | $28K | Buy |
199
+29
| +17% | +$4.73K | ﹤0.01% | 1042 |
|
|
2020
Q4 | $29K | Hold |
170
| – | – | 0.01% | 955 |
|
|
2020
Q3 | $24K | Hold |
170
| – | – | 0.01% | 896 |
|
|
2020
Q2 | $20K | Buy |
170
+3
| +2% | +$356 | ﹤0.01% | 1069 |
|
|
2020
Q1 | $17K | Hold |
167
| – | – | ﹤0.01% | 1329 |
|
|
2019
Q4 | $19K | Hold |
167
| – | – | ﹤0.01% | 1721 |
|
|
2019
Q3 | $14K | Hold |
167
| – | – | ﹤0.01% | 1702 |
|
|
2019
Q2 | $10K | Hold |
167
| – | – | ﹤0.01% | 1807 |
|
|
2019
Q1 | $10K | Hold |
167
| – | – | ﹤0.01% | 1708 |
|
|
2018
Q4 | $6K | Buy |
+167
| New | +$7.42K | ﹤0.01% | 1604 |
|
|
2018
Q3 | – | Sell |
-95
| Closed | -$7K | – | 2199 |
|
|
2018
Q2 | $7K | Hold |
95
| – | – | ﹤0.01% | 1455 |
|
|
2018
Q1 | $8K | Buy |
+95
| New | +$7.67K | ﹤0.01% | 1373 |
|
Other funds holding NVRO
Quadrant Capital Group's NVRO Position: Q2 2025 in Review
Quadrant Capital Group sold out of NEVRO CORP. (NVRO) in Q2 2025, closing a stake of 59 shares — an estimated $345 sold.
Quadrant Capital Group first reported a position in NVRO in Q1 2018 and held it in 28 quarters. The position peaked at $30K in Q4 2021. 1 fund tracked by Wall St. Rank holds NVRO as of Q2 2025.
- Quadrant Capital Group reported no remaining NEVRO CORP. position as of Q2 2025 after selling out during the quarter.
- Quadrant Capital Group sold 59 NEVRO CORP. shares in Q2 2025, an estimated $345.
- Quadrant Capital Group first reported a position in NEVRO CORP. in Q1 2018 and held it in 28 quarters.
- Quadrant Capital Group's NEVRO CORP. position peaked at $30K in Q4 2021.
- 1 fund tracked by Wall St. Rank held NEVRO CORP. as of Q2 2025.
Based on Quadrant Capital Group's 13F filing for Q2 2025, filed 13 Aug 2025.